Apnimed, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Apnimed is a new pharmaceutical company dedicated to breathing new life into sleep-related breathing disease treatment landscape through innovation in oxygenation. If approved, AD109 could be the first pharmacological treatment to improve oxygenation during sleep by directly addressing the underlying neuromuscular cause of upper airway collapse in people with Obstructive Sleep Apnea with a pill.
Contact Information
39 John F. Kennedy St., 4th Floor
Cambridge, MA 02138
https://apnimed.com/Services Offered
Branded
Staff
-
Griesbach, Robert
Director, Trade Operations, Apnimed, Inc. -
Yerges, Rachael
National Account Director, Apnimed, Inc.
- of 1